Anatomic and Hormonal Changes in the Female Reproductive Tract Immune Environment during the Life Cycle: Implications for HIV/STI Prevention Research

American Journal of Reproductive Immunology

Volumn 71, Issue 6, 2014, Pages 495-504

  Venkatesh, Kartik K ^a   Cu Uvin, Susan ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Anatomy; Female genital tract; HIV; Hormones; STI; Women

Indexed keywords

ESTRADIOL; PROGESTERONE; SEX HORMONE;

ARTICLE; BIRTH; ESTRADIOL BLOOD LEVEL; FEMALE GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIFE CYCLE; MENOPAUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEXUALLY TRANSMITTED DISEASE; VIRUS IMMUNITY; VIRUS PATHOGENESIS; ANATOMY AND HISTOLOGY; FEMALE; IMMUNOLOGY; MENSTRUAL CYCLE; METABOLISM; MICROBIOLOGY; MUCOSA; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; TRANSMISSION; VIROLOGY;

ESTRADIOL; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MENSTRUAL CYCLE; MUCOUS MEMBRANE; PROGESTERONE; SEXUAL DEVELOPMENT; SEXUALLY TRANSMITTED DISEASES;

EID: 84900547549     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12247     Document Type: Article

References (69)

1. UNAIDS. UNAIDS/WHO AIDS epidemic update. 2011; http://www.who.int/hiv/pub/progress_report2011/en/index.html. Accessed May 20, 2013.
2. Langer JE, Oliver ER, Lev-Toaff AS, Coleman BG: Imaging of the female pelvis through the life cycle. Radiographics 2012; 32:1575-1597.
3. Rodriguez-Garcia M, Patel MV, Wira CR: Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol 2013; 97:74-84.
4. Prior JC: Perimenopause lost-reframing the end of menstruation. J Reprod Infant Psychol 2006; 24:323-335.
5. Shacklett BL, Greenblatt RM: Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am J Reprod Immunol 2011; 65:230-241.
6. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV: Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011; 65:196-211.
7. Case AM, Reid RL: Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998; 158:1405-1412.
8. Farage MA, Neill S, MacLean AB: Physiological changes associated with the menstrual cycle: a review. Obstet Gynecol Surv 2009; 64:58-72.
9. Channing C, Schaerf FW, Anderson LD, Tsafriri A: Ovarian follicular and luteal physiology. Int Rev Physiol 1980; 22:117-201.
10. Oertelt-Prigione S: immunology and the menstrual cycle. Autoimmun Rev 2012; 11:A486-A492.
11. Usala SJ, Usala FO, Haciski R, Holt JA, Schumacher GF: IgG and IgA content of vaginal fluid during the menstrual cycle. J Reprod Med 1989; 34:292-294.
12. Hickey DK, Patel MV, Fahey JV, Wira CR: Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 2011; 88:185-194.
13. Benki S, Mostad SB, Richardson BA, Mandaliya K, Kreiss JK, Overbaugh J: Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis 2004; 189:2192-2201.
14. Money D, Arikan YY, Remple V, Sherlock C, Craib K, Birch P, Burdge DR: Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus. Am J Obstet Gynecol 2003; 188:122-128.
15. Fahey JV, Bodwell JE, Hickey DK, Ghosh M, Muia MN, Wira CR: New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol 2011; 65:334-343.
16. Park D, Yang KM: Hormonal regulation of uterine chemokines and immune cells. Clin Exp Reprod Med 2011; 38:179-185.
17. Dunbar B, Patel M, Fahey J, Wira C: Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors. Mol Cell Endocrinol 2012; 354:85-93.
18. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.
19. Saba E, Origoni M, Taccagni G, Ferrari D, Doglioni C, Nava A, Lisco A, Grivel JC, Margolis L, Poli G: Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol 2013; 6:1081-1090.
20. White H, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, Green WR, Wira CR: CD3 + CD8 + CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158:3017-3027.
21. White H, Yeaman GR, Givan AL, Wira CR: Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol 1997; 37:30-38.
22. Curlin M, Leelawiwat W, Dunne EF, Chonwattana W, Mock PA, Mueanpai F, Thep-Amnuay S, Whitehead SJ, McNicholl JM: Cyclic changes in HIV shedding from the female genital tract during the menstrual cycle. J Infect Dis 2013; 207:1616-1620.
23. Miller C, Li Q, Abel K, Kim EY, Ma ZM, Wietgrefe S, La Franco-Scheuch L, Compton L, Duan L, Shore MD, Zupancic M, Busch M, Carlis J, Wolinsky S, Haase AT: Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79:9217-9227.
24. Haase A: The pathogenesis of sexual mucosal transmission and early stages of infection: obstacles and a narrow window of opportunity for prevention. AIDS 2001; 15(Suppl 1):S10-S11.
25. Shattock R, Moore JP: Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003; 1:25-34.
26. Yeaman GR, White HD, Howell A, Prabhala R, Wira CR: The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S57-S62.
27. Yeaman GR, Howell AL, Weldon S, Demian DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW: Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109:137-146.
28. Asin SN, Fanger MW, Wildt-Perinic D, Ware PL, Wira CR, Howell AL: Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis 2004; 190:236-245.
29. Mutter G, Ferenczy A: Anatomy and histology of the uterine corpus. In Blaustein's Pathology of the Female Genital Tract, R Kurman (ed.). New York, Springer, 2002, pp 257-289.
30. Clement P: Anatomy and histology of the ovary. In Blaustein's Pathology of the Female Genital Tract, R Kurman (ed.). New York, Springer, 2002, pp 438-464.
31. Wright T, Ferenczy A: Anatomy and histology of the cervix. In Blaustein's Pathology of the Female Genital Tract, R Kurman (ed.). New York, Springer, 2002, pp 185-199.
32. Moench TR, Chipato T, Padian NS: Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 2001; 15:1595-1602.
33. Levine WC, Pope V, Bhoomkar A, Tambe P, Lewis JS, Zaidi AA, Farshy CE, Mitchell S, Talkington DF: Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-174.
34. Hwang LY, Scott ME, Ma Y, Moscicki AB: Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol 2011; 88:66-71.
35. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD: In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 1998; 72:5035-5045.
36. Hussain LA, Lehner T: Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995; 85:475-484.
37. Meditz A, Moreau KL, MaWhinney S, Gozansky WS, Melander K, Kohrt WM, Wierman ME, Connick E: CCR5 expression is elevated on endocervical CD4 + T cells in healthy postmenopausal women. J Acquir Immune Defic Syndr 2012; 59:221-228.
38. Shukair S, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, Lakougna HY, Hammond C, Kiser PF, Hope TJ: Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 2013; 6:427-434.
39. Jacobson DL, Peralta L, Graham NM, Zenilman J: Histologic development of cervical ectopy: relationship to reproductive hormones. Sex Transm Dis 2000; 27:252-258.
40. Jordan J, Singer S, eds: The Cervix. London, WB Saunders, 1976.
41. Venkatesh KK, Cu-Uvin S: Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women. Am J Reprod Immunol 2013; 69(Suppl 1):68-73.
42. Goldacre MJ, Loudon N, Watt B, Grant G, Loudon JD, McPherson K, Vessey MP: Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J 1978; 1:748-750.
43. Madile BM: The Cervical Epithelium From Fetal Age to Adolescence. Obstet Gynecol 1976; 47:536-539.
44. Moscicki AB, Ma Y, Holland C, Vermund SH: Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 2001; 183:865-870.
45. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, Kiviat NB, Koutsky LA, Stevens CE, Holmes KK: Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534-543.
46. Toon PG, Arrand JR, Wilson LP, Sharp DS: Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) 1986; 293:1261-1264.
47. Collier AC, Handsfield HH, Ashley R, Roberts PL, DeRouen T, Meyers JD, Corey L: Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 1995; 171:33-38.
48. Louv WC, Austin H, Perlman J, Alexander WJ: Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-402.
49. Thurman A, Doncel GF: Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol 2011; 65:89-98.
50. Rollenhagen C, Lathrop MJ, Macura SL, Doncel GF, Asin SN: Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides. Mucosal Immunol 2014; In press.
51. Thurman A, Doncel GF: Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention. Int J STD AIDS 2012; 23:613-619.
52. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, Nalugoda F, Kiddugavu M, Sewankambo N, Quinn TC, Reynolds SJ, Wawer MJ: Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.
53. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG: Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS 1998; 12:197-203.
54. Gray RH, Wabwire-Mangen F, Kigozi G, Sewankambo NK, Serwadda D, Moulton LH, Quinn TC, O'Brien KL, Meehan M, Abramowsky C, Robb M, Wawer MJ: Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209-1217.
55. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, Mugerwa R, Padian N, Rugpao S, Brown JM, Cornelisse P, Salata RA: Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
56. Jacobson DL, Peralta L, Farmer M, Graham NM, Gaydos C, Zenilman J: Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 2000; 27:313-319.
57. Brabin L: Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression. AIDS Patient Care STDS 2002; 16:211-221.
58. Donders GG, Vereecken A, Bosmans E, Spitz B: Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol 2003; 189:1433-1438.
59. Walter J, Fraga L, Orin MJ, et al.: Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study. BMC Infect Dis 2011; 11:263.
60. Anderson BL, Ghosh M, Raker C, Fahey J, Song Y, Rouse DJ, Wira CR, Cu-Uvin S: In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women. Am J Obstet Gynecol 2012; 207:65.e1-e10.
61. Blish CA, Baeten JM: Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol 2011; 65:302-307.
62. Morrison C, Fichorova R, Mauck C, Chen P, Kwok C, Chipato T, Salata R, Doncel GF: Cervical Inflammation and Immunity Associated with Hormonal Contraception, Pregnancy and HIV-1 Seroconversion. J Acquir Immune Defic Syndr 2014; In press.
63. Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL: The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999; 60:15-24.
64. Ildgruben AK, Sjoberg IM, Hammarstrom ML: Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet Gynecol 2003; 102:571-582.
65. Bahamondes L, Trevisan M, Andrade L, Marchi NM, Castro S, Diaz J, Faundes A: The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 2000; 62:23-27.
66. Kafka JK, Sheth PM, Nazli A, Osborne BJ, Kovacs C, Kaul R, Kaushic C: Endometrial epithelial cell response to semen from HIV-infected men during different stages of infection is distinct and can drive HIV-1-long terminal repeat. AIDS 2012; 26:27-36.
67. van de Wijgert J, Shattock RJ: Vaginal microbicides: the importance of effective distribution, retention and coating of the mucosa. AIDS 2008; 22:1231-1232.
68. Doncel G, Joseph T, Thurman AR: Role of semen in HIV-1 transmission: inhibitor or facilitator? Am J Reprod Immunol 2011; 65:292-301.
69. Moore J, Shattock RJ: Preventing HIV-1 sexual transmission-not sexy enough science, or no benefit to the bottom line? J Antimicrob Chemother 2003; 52:890-892.